000 01505 a2200397 4500
005 20250514181232.0
264 0 _c20040921
008 200409s 0 0 eng d
022 _a1388-9842
024 7 _a10.1016/j.ejheart.2003.09.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBahrmann, Philipp
245 0 0 _aPentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.
_h[electronic resource]
260 _bEuropean journal of heart failure
_cMar 2004
300 _a195-201 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aCardiomyopathy, Dilated
_xblood
650 0 4 _aDouble-Blind Method
650 0 4 _aEchocardiography
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNatriuretic Peptide, Brain
_xblood
650 0 4 _aPentoxifylline
_xpharmacology
650 0 4 _aProspective Studies
650 0 4 _aTumor Necrosis Factor-alpha
_xanalysis
650 0 4 _aVasodilator Agents
_xpharmacology
650 0 4 _aVentricular Function, Left
_xdrug effects
700 1 _aHengst, Uta M
700 1 _aRichartz, Babara M
700 1 _aFigulla, Hans R
773 0 _tEuropean journal of heart failure
_gvol. 6
_gno. 2
_gp. 195-201
856 4 0 _uhttps://doi.org/10.1016/j.ejheart.2003.09.005
_zAvailable from publisher's website
999 _c14705925
_d14705925